Euroapi S.A.

Paris Stock Exchange EAPI.PA

Euroapi S.A. EBITDA for the year ending December 31, 2023: USD 78.37 M

Euroapi S.A. EBITDA is USD 78.37 M for the year ending December 31, 2023, a 2.87% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Euroapi S.A. EBITDA for the year ending December 31, 2022 was USD 76.18 M, a 7.25% change year over year.
Euroapi S.A. EBITDA for the year ending December 31, 2021 was USD 71.03 M, a -5.60% change year over year.
Euroapi S.A. EBITDA for the year ending December 31, 2020 was USD 75.25 M, a 15.41% change year over year.
Euroapi S.A. EBITDA for the year ending December 31, 2019 was USD 65.20 M.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Paris Stock Exchange: EAPI.PA

Euroapi S.A.

CEO	Mr. Ludwig De Mot
IPO Date	May 6, 2022
Location	France
Headquarters	15 Rue Traversiere
Employees	3,650
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.

Key trends

Past 5 years